Recent Finacing
Recent Raise
En Carta Diagnostics develops a point-of-care molecular diagnostics platform using aptamer-based programmable signature cassettes to rapidly detect genetic, pathogenic, and veterinary targets, initially offering a minutes-scale Lyme disease test.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor